Diffuse Retinal Whitening Signifies Acute Retinal Necrosis
By:  Boris V. Stanzel, MD; Claudia Inhetvin-Hutter, MD; Frank G. Holz, MD
Early vitrectomy and silicone oil tamponade may preserve relatively good visual function

Therapeutics Update in Noninfectious Uveitis
By:  Joseph J. Tseng, MD; Howard F Fine, MD, MHSc

Overcoming Myths and Misconceptions in Small-gauge Vitreoretinal Surgery
By:  J. Fernando Arevalo, MD, FACS; Maria H. Berrocal, MD
Recent enhancements have expanded the indications and improved outcomes

The Future of the Academic Ophthalmologist
By:  Franco M. Recchia, MD; Brian R. Carlson, MBA; Paul Sternberg, Jr.,, MD

Do Alternative Treatments for CNV Have a Place in the Era of VEGF Inhibition?
By:  Kartik Kumar, MD; R.C. Andrew Symons, MB BS, PhD, FRANZCO

Clinical Trials in Practice: The Business of Drug Approval
By:  Andrew E. Mathis, PhD, Medical Editor
Participating in clinical trials can be advantageous to both clinicians and their patients

Retinal Lasers: Past, Present, and Future
By:  Michael D. Ober, MD; Seenu M. Hariprasad, M.D.
Technological advancement flourished early on, then plateaued. What's in store next? Part 1 of 2

Post-vitrectomy Diabetic Vitreous Hemorrhage: Etiology, Clinical Management, and Prevention
By:  Yoel Greenwald, MD; Ayala Pollack, MD; Guy, Kleinmann, MD

Ocular Toxoplasmosis as the Presenting Sign of AIDS
By:  Ahmad A. Aref, MD; Kimberly A. Neely, MD, PhD; Ingird U. Scott, MD, MPH
Neuroimaging was instrumental in confirming the diagnosis

Upfront
By:  Jason S. Slakter, M.D.
From the editor-in-chief

Subspecialty News
By:  Blair B. Lonsberry, O.D., M.S., F.A.A.O.
“Women in Retina” group and more

Coding Q&A
By:  Riva Lee Asbell
Don’t presume that you can’t break a bundle

Focus on ...
By:  Leslie Goldberg, Associate Editor
Bausch & Lomb's Millennium Vitrectomy Enhancer

Clinical Trial Spotlight
By:  Andrew E. Mathis, PhD, Medical Editor
Niacin/steroid combination for RVO

Clinical Trials Update